← FDA DRUG APPROVALS

FDA ANDA · ANDA040276

PHENTERMINE HYDROCHLORIDE

Sponsor: ACTAVIS ELIZABETH

APPLICATION
ANDA040276
TYPE
ANDA
ORIGINAL APPROVAL
1998-11-25
LATEST ACTION
2017-05-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PHENTERMINE HYDROCHLORIDEDiscontinued
PHENTERMINE HYDROCHLORIDE 37.5MG · TABLET · ORAL

Approval history

2017-05-31Labeling · Supplement 16 · standardAP
2015-11-04Labeling · Supplement 15 · standardAP
2001-11-02Manufacturing (CMC) · Supplement 2AP
2001-04-04Manufacturing (CMC) · Supplement 1AP
1998-11-25OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →